Clinical Trial Technology Editorial

  1. Clinical News Roundup: FDA Rejects Evidence For Muscular Dystrophy Drug

    Clinical Leader news roundup for the week of April 25, 2016, with articles on the FDA rejecting a Duchenne muscular dystrophy treatment, Lilly, Merck, and Pfizer sharing patient recruitment success stories, machines making clinical trials more successful, using cannabis to treat epilepsy, metaform prolonging the effects of old age, and more.

  2. Can Digitizing Clinical Trials Help Reverse Eroom’s Law?

    Eroom’s Law models the decline in R&D efficiency of traditional pharmaceutical therapies.  Basically, it explains that even with the tremendous and continued advancements in technology—processing power, storage, and bandwidth capability (Eroom is Moore spelled backwards, as in Moore’s Law)—the R&D cost to bring a new drug to market is still increasing linearly.

  3. Speeding Research With Data Mining Expertise

    According to The STM Report (2015), more than 2.5 million peer-reviewed articles are published in scholarly journals each year. PubMed alone contains more than 25 million citations for biomedical journal articles from MEDLINE. The amount and availability of content for clinical researchers has never been greater – but finding the right articles to use is becoming more difficult.

  4. NEWS ROUNDUP: Precision Medicine And Patient Data, FDA Accuses CRO Of Data Fudging

    Clinical Leader news roundup for the week of April 18, 2016, with articles on precision medicine and whether it can compromise patient data, FTC help for mobile health app developers, retrospectively registered clinical trials, stem cell research and clinical trials, new patient engagement tools, and data fudging in India.

  5. The True Disruptors In Clinical Trials: Insights From Agile, Merck, BI, And EMD Serono

    Innovation is shaking up the world of clinical trials. Advancements in technology are rapidly changing the landscape of data collection and analysis, while patients and patient advocacy groups do their best to get their voices heard in the process of planning and executing trials. But while we often hear references to disruptions in clinical trials, it can often be difficult to identify exactly what is disrupting the process.

  6. NEWS ROUNDUP: Pharma Invests In Patients, More Trials Use FitBit Trackers

    Clinical Leader news roundup for the week of April 11, 2016, with articles on pharma’s investment in patients, FitBit activity trackers in clinical trials, new Hep C combination treatment tested in Malaysia and Thailand, prostate and pancreatic cancer trials, the need for clinical trial participants, and making the most of clinical trial data.

  7. NEWS ROUNDUP: Santa Claus, The Easter Bunny, And Patient Centricity?

    Clinical Leader news roundup for the week of April 4, 2016, with articles on Patient recruitment via Twitter, NIH sponsors trial of anti-HIV antibody, diversity in clinical trials, INC Research partners with CISCRP, the use of apps in clinical trials, and the myth of patient centricity.

  8. EMRs Will Revolutionize Clinical Trials…But Don’t Hold Your Breath

    Will EMRs revolutionize clinical trials? The answer to that question might be a yes or no, depending on who you talk to. “People in this industry talk about how great it would be if EMRs could talk to each other,” says Ed Seguine, CEO of Clinical Ink. “But when you look at what is going on in the real world, two hospitals across the street from each other cannot get their EMRs to work together.

  9. In A Clinical Trial, Can Fitness Trackers Actually Track Fitness?

    Many in the clinical space have been anxiously waiting for wearable devices to make it into clinical trials. The benefits they might provide to patients can be great, and we seem to be solving problems related to privacy and data collection. But how accurate are many of the devices currently on the market?

  10. The Future Of Data And Technology In Clinical Trials

    In advance of its upcoming Data & Technology in Clinical Trials 2016 conference, eyeforpharma has released a report on the future of data and technology adoption in clinical trials. An Industry View Point: The Future of Leveraging Data & Technology in Clinical Trials takes a detailed look at the impact of data collection and analysis methods, current challenges, and patient centricity.